image: The personalized vaccine is composed of the patient's dendritic cells, which were harvested from serum samples (steps 4-6). The cells were then exposed to a solution of material previously gathered from the tumor (steps 1-3) before being injected back into the patient in vaccine form (steps 7-8). This material relates to a paper that appeared in the 11 April, issue of Science Translational Medicine, published by AAAS. The paper, by J.L. Tanyi at University of Pennsylvania in Philadelphia, PA, and colleagues was titled, "Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer." view more
Credit: J.L. Tanyi <i>et al., Science Translational Medicine </i>(2018)